<DOC>
	<DOCNO>NCT00498979</DOCNO>
	<brief_summary>RATIONALE : Sodium stibogluconate may stop growth tumor cell block enzymes need cell growth . Interferon alfa-2b may interfere growth tumor cell slow growth melanoma cancer . Drugs use chemotherapy , cisplatin , vinblastine , dacarbazine , work different way stop growth tumor cell , either kill cell stop divide . Giving sodium stibogluconate interferon alfa-2b together combination chemotherapy may kill tumor cell . PURPOSE : This phase I trial study side effect best dose sodium stibogluconate give together interferon alfa-2b , cisplatin , vinblastine , dacarbazine treat patient advanced melanoma cancer .</brief_summary>
	<brief_title>Sodium Stibogluconate IFNa-2b Followed By CDDP , VLB DTIC Treating Pts.With Advanced Melanoma Other Cancers</brief_title>
	<detailed_description>OBJECTIVES : Primary - To determine safety combination sodium stibogluconate interferon alfa-2b chemotherapy . - To confirm activity sodium stibogluconate augment cytokine effect . Secondary - To quantify effect sodium stibogluconate interferon alfa-2b induced gene modulation signal transduction pathway measure serum soluble gene product . - To define effectiveness sodium stibogluconate inhibit protein tyrosine phosphatase SHP-1 SHP-2 assayed peripheral blood leukocytes patient receive sodium stibogluconate combination interferon alfa-2b . - To define pharmacokinetics sodium stibogluconate serum escalate dos . - To assess clinical response combination sodium stibogluconate interferon alfa-2b priming combination chemotherapy . OUTLINE : - Course 1 : Patients receive sodium stibogluconate IV 15 minute day 1 day 15-18 ; interferon alfa-2b subcutaneously ( SC ) day 8-12 15-18 ; cisplatin IV 30-60 minute vinblastine IV day 19 20 ; dacarbazine . After 2-week rest period , patient proceed course 2 . - Course 2 subsequent course : Patients receive sodium stibogluconate IV 15 minute interferon alfa-2b SC day 1-4 ; cisplatin IV 30-60 minute vinblastine IV day 5 6 ; dacarbazine . Courses repeat every 4 week absence disease progression unacceptable toxicity . * NOTE : *Patients stage IV disease evidence disease [ NED } receive 4 course therapy . Cohorts 6 patient receive escalate dos sodium stibogluconate maximum tolerate dose ( MTD ) determine . The MTD define dose precede dose-limiting toxicity occur ( i.e. , 1 patient give dose experience DLT ) . Patients undergo blood sample collection periodically immunological pharmacokinetic study . Samples analyze serum soluble gene product protein tyrosine phosphatase inhibition .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Antimony Sodium Gluconate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm melanoma malignancy Must refractory resistant establish treatment OR metastatic disease effective therapy establish Gliomas control CNS metastasis allow A CT scan MRI must confirm stable brain metastasis within 28 day study entry Patients primary CNS malignancy refractory therapy eligible Malignancy potentially responsive sodium stibogluconate and/or interferon alfa2b combination chemotherapy Patients must measurable evaluable disease Evaluable disease include clinically radiographically nonmeasurable tumor , specific tumor marker , stage IV patient evidence disease ( NED ) PATIENT CHARACTERISTICS : Inclusion criterion : ECOG performance status 02 Granulocytes &gt; 1,500/μl Platelets &gt; 100,000/μl Creatinine &lt; 1.5 x upper limit normal ( ULN ) Bilirubin &lt; 1.5 x ULN AST ALT &lt; 1.5 x ULN ( unless due hepatic metastasis ) Potassium ≤ 5.0 mmol/L Magnesium ≤ 2.4 mg/dL Creatinine clearance ≥ 60 cc/min Ejection fraction ≥ 50 % Exclusion criterion : Pregnant lactate woman fertile woman men unless surgically sterile use effective contraception All female patient childbearing potential less 1 year postmenopausal must negative βHCG pregnancy test baseline practice medically acceptable method birth control ( i.e. , oral contraceptive least 3 month , implantation intrauterine device least 2 month , barrier method [ e.g. , vaginal diaphragm , vaginal sponge , condom spermicidal jelly ] ) 3 month study initiation History atrial fibrillation , flutter , serious arrhythmia ( exclude asymptomatic atrial ventricular premature complex ) past 24 month History congestive heart failure currently require treatment ; angina pectoris ; severe cardiovascular disease ( i.e. , New York Heart Association class III IV heart disease ) Baseline ECG abnormality suggestive cardiac conduction delay ( i.e. , first degree great atrioventricular block and/or complete incomplete [ QRS &gt; 120 m ] bundle branch block ) Baseline ECG abnormality suggestive repolarization abnormality ( i.e. , QTc ≥ 0.48 sec ) Culture positive acute infection require antibiotic within past 14 day Patients long term suppressive antibiotic therapy eligible Known positive HBsAg Patients judge psychologically prepared understand inform consent comply investigational study PRIOR CONCURRENT THERAPY : Inclusion criterion : Prior interferon therapy allow administer ≥ 4 month ago At least 3 week since prior major surgery , radiation therapy , chemotherapy Exclusion criterion : No prior treatment interferon , sodium stibogluconate , cisplatin , vinblastine , dacarbazine , except give adjuvant setting Patients prior history solid organ allograft allogeneic bone marrow transplant Patients take follow medication eligible : Amiodarone ( Cordarone ) Disopyramide ( Norpace ) Dofetilide ( Tikosyn ) Procainamide ( Procanbid Pronestyl ) Quinidine ( Quinaglute ) Sotalol ( Betapace ) Erythromycin Azithromycin ( Zpack ) Clarithromycin ( Biaxin ) Pentamidine ( Pentacarinat ) Trimethoprimsulfamethoxazole ( Bactrim ) Bepridil ( Vascor ) Phenothiazines ( e.g. , prochlorperazine [ Compazine ] , promethazine [ Phenergan ] , chlorpromazine [ Thorazine ] ) Butyrophenones ( e.g. , Haloperidol [ Haldol ] ) Risperidone ( Risperdal ) Any antipsychotic medication Tricyclic tetracyclic antidepressant ( e.g. , imipramine [ Tofranil ] , amitriptyline [ Elavil ] , desipramine [ Norpramin ] , nortriptyline [ Pamelor ] ) Monoamine oxidase inhibitor Highdose methadone Arsenic trioxide Dolasetron ( Anzemet ) Any herbal preparation Use daily glucocorticoid except physiological replacement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>stage IV melanoma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>mixed glioma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult subependymal giant cell astrocytoma</keyword>
	<keyword>adult pineal gland astrocytoma</keyword>
</DOC>